These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1574541)

  • 21. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients.
    Garver DL; Bissette G; Yao JK; Nemeroff CB
    Am J Psychiatry; 1991 Apr; 148(4):484-8. PubMed ID: 2006695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic therapy following neuroleptic malignant syndrome.
    Pelonero AL; Levenson JL; Silverman JJ
    Psychosomatics; 1985 Dec; 26(12):946-7. PubMed ID: 4089133
    [No Abstract]   [Full Text] [Related]  

  • 25. Haloperidol blood levels in acute mania with psychosis.
    Chou JC; Czobor P; Dacpano G; Richardson N; Tuma I; Trujillo M; Cooper TB; Volavka J
    J Clin Psychopharmacol; 2001 Aug; 21(4):445-7. PubMed ID: 11476130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first lithium clinic in Hong Kong: a Chinese profile.
    Lee S
    Aust N Z J Psychiatry; 1992 Sep; 26(3):450-3. PubMed ID: 1417631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
    Robinson S; Rosca P; Durst R; Shai U; Ghinea C; Schmidt U; Nir I
    Acta Psychiatr Scand; 1991 Sep; 84(3):221-4. PubMed ID: 1950621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of depot neuroleptic haloperidol decanoate.
    Fernando J; Krishna Raju R; Jones GG; Stanley RO
    Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol.
    Odou P; Vaiva G; Luyckx M; Brunet C; Dine T; Gressier B; Cazin M; Cazin JC
    Eur J Clin Pharmacol; 1996; 50(5):357-63. PubMed ID: 8839656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?
    Harrow M; Yonan CA; Sands JR; Marengo J
    Schizophr Bull; 1994; 20(2):327-38. PubMed ID: 8085135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large variations of plasma levels during maintenance treatment with depot neuroleptics.
    Tuninger E; Levander S
    Br J Psychiatry; 1996 Nov; 169(5):618-21. PubMed ID: 8932892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lowest effective dose of depot neuroleptics.
    Hoencamp E; Haffmans PJ; Jansen GS
    Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
    [No Abstract]   [Full Text] [Related]  

  • 37. Full circle-old drugs prove more beneficial than newer agents for schizophrenia: a case report.
    Veronin MA; Colson K; Roffman ME; Roman MW
    Issues Ment Health Nurs; 2012 Nov; 33(11):797-800. PubMed ID: 23146014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacological treatment of delusional depression.
    Spiker DG; Weiss JC; Dealy RS; Griffin SJ; Hanin I; Neil JF; Perel JM; Rossi AJ; Soloff PH
    Am J Psychiatry; 1985 Apr; 142(4):430-6. PubMed ID: 3883815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
    Mazure CM; Bowers MB
    J Affect Disord; 1998 Feb; 48(1):83-6. PubMed ID: 9495606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.